Abstracts / posters
| Product | Conference | Title | Download |
| TB-402 | 21st International Congress on Thrombosis: July 6-9, 2010, Milan, Italy | Single intravenous administration of TB-402 for the prophylaxis of VTE after total knee replacement surgery |  |
| TB-403 | AACR-NCI-EORTC International Conference, Molecular Targets and Cancer Therapeutics in Boston, MA, USA, Nov 09 | A phase I, dose escalation study of TB-403 in patients with solid tumors |  |
| TB-403 | AACR-NCI-EORTC International Conference, Molecular Targets and Cancer Therapeutics in Boston, MA, USA, Nov 09 | A first-in-man, phase I, dose escalation study of TB-403 in healthy male subjects | |
| BI-505 | XIIth International Myeloma Workshop in Washington DC, Feb 09 | Apoptosis-Inducing ICAM-1 Antibody BI-505 Is a Potent Inhibitor of Multiple Myeloma | |
| TB-402 | American Society of Hematology (ASH) 49th Annual Meeting in Atlanta, Georgia, USA, Dec 2007 | A Human Monoclonal Antibody Partially Inhibiting FVIII Activity: A Novel, Long-acting Antithrombotic Drug | |
BioInvent International • SE-223 70 Lund, Sweden • Visiting: Sölvegatan 41, Lund, Sweden • Tel: +46 (0)46-286 85 50 • E-mail: info@bioinvent.com